Ildong Pharmaceutical Co., Ltd.

KOSE:A249420 Voorraadrapport

Marktkapitalisatie: ₩377.6b

Ildong Pharmaceutical Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Yun Paul Woongsup

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Revenues Not Telling The Story For Ildong Pharmaceutical Co., Ltd. (KRX:249420) After Shares Rise 33%

Aug 20
Revenues Not Telling The Story For Ildong Pharmaceutical Co., Ltd. (KRX:249420) After Shares Rise 33%

Is Ildong Pharmaceutical (KRX:249420) A Risky Investment?

Aug 12
Is Ildong Pharmaceutical (KRX:249420) A Risky Investment?

If You Had Bought Ildong Pharmaceutical (KRX:249420) Shares A Year Ago You'd Have Earned 18% Returns

Jan 01
If You Had Bought Ildong Pharmaceutical (KRX:249420) Shares A Year Ago You'd Have Earned 18% Returns

CEO

Yun Paul Woongsup

no data

Tenure

Yun Paul Woongsup is Chief Executive Officer of Ildong Pharmaceutical Co., Ltd.